These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Hormone levels and tumour size response to quinagolide and cabergoline in patients with prolactin-secreting and clinically non-functioning pituitary adenomas: predictive value of pituitary scintigraphy with 123I-methoxybenzamide. Colao A, Ferone D, Lastoria S, Cerbone G, Di Sarno A, Di Somma C, Lucci R, Lombardi G. Clin Endocrinol (Oxf); 2000 Apr; 52(4):437-45. PubMed ID: 10762286 [Abstract] [Full Text] [Related]
10. Giant prolactinomas larger than 60 mm in size: a cohort of massive and aggressive prolactin-secreting pituitary adenomas. Shimon I, Sosa E, Mendoza V, Greenman Y, Tirosh A, Espinosa E, Popovic V, Glezer A, Bronstein MD, Mercado M. Pituitary; 2016 Aug; 19(4):429-36. PubMed ID: 27138902 [Abstract] [Full Text] [Related]
12. Dopaminergic tone and obesity: an insight from prolactinomas treated with bromocriptine. Doknic M, Pekic S, Zarkovic M, Medic-Stojanoska M, Dieguez C, Casanueva F, Popovic V. Eur J Endocrinol; 2002 Jul; 147(1):77-84. PubMed ID: 12088923 [Abstract] [Full Text] [Related]
20. Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution-based assessment. Sartorio A, Pizzocaro A, Liberati D, De Nicolao G, Veldhuis JD, Faglia G. Clin Endocrinol (Oxf); 2000 Jun; 52(6):703-12. PubMed ID: 10848874 [Abstract] [Full Text] [Related] Page: [Next] [New Search]